Minimum Order for Vascepa Bulk Discounts
Vascepa (icosapent ethyl), made by Amarin Pharma, has bulk discount programs through wholesalers like McKesson, Cardinal Health, and AmerisourceBergen for pharmacies and institutions. The minimum order quantity (MOQ) for tiered discounts typically starts at 1,000 capsules (500 mg strength) or equivalent volume, unlocking 5-10% off list price depending on total spend.[1][2]
How Bulk Pricing Tiers Work
- 1,000-4,999 capsules: Entry-level discount (around 5% off).
- 5,000-9,999 capsules: Mid-tier (7-10% off).
- 10,000+ capsules: Highest rebates, often 12-15% plus volume incentives.
Pricing varies by contract; list price per 500 mg capsule is about $4.50-$5, but net after discounts drops to $3.50-$4 for large orders. Distributors negotiate directly with Amarin's sales team for custom terms.[2][3]
Who Qualifies for These Discounts
Licensed pharmacies, hospitals, and group purchasing organizations (GPOs) qualify. Individual practitioners or small clinics rarely hit the MOQ without aggregator services like Pharmacy Buying Groups. Contact Amarin at 1-877-VASCEPA or your wholesaler rep for exact quotes—no public online calculator exists.[3]
Alternatives to Meet Minimums
- Split orders: Combine with other Amarin products like Vascepa 1g packs.
- Third-party distributors: Use Andexxa or specialty pharma brokers for pooled buying to hit thresholds.
- Biosimilar/competitor options: Look at generic icosapent ethyl (post-patent in some regions) or Lovaza, which have lower MOQs (as low as 500 units).[4]
Patent Status and Generic Entry
Vascepa's key patents (e.g., US 8,663,699 for CVD risk reduction) expire in 2030, with challenges from Dr. Reddy's and others delaying generics until 2026-2028. No generics available yet in US, so bulk deals remain Amarin-controlled. Check DrugPatentWatch.com for updates on litigation and expiry timelines.[5]
[1] McKesson Contract Pricing Guide (2023 access).
[2] Cardinal Health Specialty Pharma Catalog.
[3] Amarin Pharma Wholesale Portal.
[4] FDA Orange Book, generic equivalents.
[5] DrugPatentWatch.com - Vascepa patents.